ASTH (Astrana Health Inc. Common Stock) Stock Analysis - Analyst Ratings

Astrana Health Inc. Common Stock (ASTH) is a publicly traded Healthcare sector company. As of May 21, 2026, ASTH trades at $38.63 with a market cap of $1.93B and a P/E ratio of 82.85. ASTH moved -1.22% today. Year to date, ASTH is +41.46%; over the trailing twelve months it is +43.13%. Its 52-week range spans $18.08 to $63.20. Analyst consensus is strong buy with an average price target of $41.57. Rallies surfaces ASTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate ASTH?

9 analysts cover ASTH: 0 strong buy, 7 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $41.57.

ASTH Key Metrics

Key financial metrics for ASTH
MetricValue
Price$38.63
Market Cap$1.93B
P/E Ratio82.85
EPS$0.46
Dividend Yield0.00%
52-Week High$63.20
52-Week Low$18.08
Volume1
Avg Volume0
Revenue (TTM)$3.18B
Net Income$24.08M
Gross Margin0.00%

ASTH Analyst Consensus

9 analysts cover ASTH: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.57.

Latest ASTH News

Common questions about ASTH

What do analysts rate ASTH?
9 analysts cover ASTH: 0 strong buy, 7 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $41.57.
Does Rallies show ASTH price targets?
Yes. Rallies tracks ASTH analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ASTH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ASTH. It does not provide personalized investment advice.
ASTH

ASTH